Wortham Laboratories, Inc. is an emerging leader in the field of hemostatic wound healing and coagulation products. Their flagship product, SeraSeal, is the world's first primary hemostatic agent, designed to stop bleeding in various blood loss situations. With over one million successful cases worldwide, SeraSeal has proven to improve surgical efficiency, reduce healthcare costs, and significantly impact patient outcomes.
Wortham Laboratories is dedicated to developing products that save lives, increase surgical efficiency, and assist first responders in providing optimal care to injured patients. Their international headquarters are located in Chattanooga, Tennessee, and they have a global distributor network. With a strong commitment to exceptional products and outstanding technical service, Wortham Laboratories continues to lead the way in advancing modern medicine.
Generated from the website